test

Steve R. Bailey

@Frazier Life Sciences Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$2.495BTotal holdings53
Assets growth rate16.72%Assets growth rate (2-Q avg)3.46%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Frazier Life Sciences Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 53 positions.

Assets under management

The assets under management (AUM) of Frazier Life Sciences Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.495B in assets, with a quarterly growth rate of 16.72% and a 2-quarter average growth rate of 3.46%. The portfolio is managed by Steve R. Bailey, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CERECerevel Therapeutics Hldng I
Recent Activity
Exited
0%
$16.07M
393,000 shares@ $40.89 avg price
APLTApplied Therapeutics Inc
Recent Activity
Exited
0%
$10.676M
2.286M shares@ $4.67 avg price
ANTXAn2 Therapeutics Inc
Recent Activity
Exited
0%
$4.491M
2.089M shares@ $2.15 avg price
MGXMetagenomi Inc
Recent Activity
Exited
0%
$1.002M
245,692 shares@ $4.08 avg price